Brief Review of the 3T's Roadmap of Translational Medicine for Parenteral and Enteral Nutrition in China

Till 2020, parenteral and enteral nutrition in China has moved from Translation 1 (T1), and then Translation 2 (T2), to Translation 3 (T3) now. The T3 transfer requires the evaluation of medical services' quality and cost-effectiveness research. After learning from international published articles, the multicenter cooperative database group of Chinese Society for Parenteral and Enteral Nutrition (CSPEN) on Nutritional risk, Undernutrition, Support, Outcome, and Cost-effectiveness ratio (NUSOC) (abbreviated to CSPEN-NUSOC Cooperative Group) has made efforts to promote health economics research in the field of parenteral and enteral nutrition in China. This paper reviewed the translational medical research of parenteral and enteral nutrition in China. At present, clinical studies toward the goal of "reasonable use to benefit patients"should be conducted in parenteral and enteral nutrition field in China, such as clinical effectiveness study of nutritional risk screening 2002 and Global Leadership Initiative on Malnutrition criteria, or health economics study on nutritional drug.